Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Mater continues to buck the gender inequity trend
Mater is bucking the gender inequity trend with an executive team that is 67 per…
Studying cancer cell signaling in microgravity conditions aboard the space station
An investigation from biotechnology startup MicroQuin launching to the International Space Station (ISS) on Northrop…
Early detection tech and the battle to change the story on ovarian cancer
Driven by a promise to help women win the battle against ovarian cancer, Dr Cesar…
The long-term financial toll of breast cancer
The financial fallout from breast cancer can last years after diagnosis, particularly for those with lymphedema, a common side effect…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.